© 2022 MJH Life Sciences and Modern Retina. All rights reserved.
© 2022 MJH Life Sciences™ and Modern Retina. All rights reserved.
August 09, 2021
Long-term sustained-release therapy pays off in management of chronic, vision-threatening disease.
August 02, 2021
New opportunities continue to develop in an evolving landscape.
July 21, 2021
Why investigators are considering AMD to be a disease spectrum rather than a single disease.
July 15, 2021
Promoting Tie2 signaling activity may complement inhibition of VEGF in addressing pathology in disease states characterized by angiogenesis, vascular permeability, and inflammation.
June 18, 2021
According to investigators, the new technology is designed to detect telltale signs of major blinding diseases in retinal blood and tissue that typically go unseen until it is too late.
May 05, 2021
Daniel F. Kiernan, MD, discusses key findings of a clinical study analyzing the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on OCT testing following vitreoretinal surgery.